Plain-English translation of NCT07043413 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
If you've had a stroke treated with emergency clot-removal surgery (called endovascular thrombectomy), this study asks you to donate the clot that was removed. Researchers will examine the clot's structure and genetic patterns to better understand what caused your stroke and predict your risk of future stroke or other heart and blood vessel problems. You'll also receive the best standard medical care and be monitored for two years.
Doctors know that strokes happen in different ways — some from fatty buildup in blood vessels, others from heart problems — but it's hard to predict who will have another stroke. By studying the actual clots removed during surgery, researchers hope to identify patterns that explain what caused each patient's stroke and warn them about future risks.
You likely qualify if…
You likely don't qualify if…
You will donate the blood clot that was already removed during your stroke surgery. After that, you will receive standard stroke care and monitoring according to current medical guidelines. You'll visit an outpatient clinic regularly for up to two years, where doctors will check for any new strokes, bleeding, or other heart and blood vessel problems. During this time, your clot will be analyzed in the laboratory to study its characteristics.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
South Korea
Enrollment target
~500 participants
Started
January 2022
Primary completion
December 2028
Last updated on clinicaltrials.gov in June 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.